<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30576507</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-3503</ISSN><JournalIssue CitedMedium="Internet"><Volume>113</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Transactions of the Royal Society of Tropical Medicine and Hygiene</Title><ISOAbbreviation>Trans R Soc Trop Med Hyg</ISOAbbreviation></Journal><ArticleTitle>Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.</ArticleTitle><Pagination><StartPage>110</StartPage><EndPage>115</EndPage><MedlinePgn>110-115</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/trstmh/try126</ELocationID><Abstract><AbstractText Label="BACKGROUND">Micronutrient deficiencies may contribute to reduced oral vaccine immunogenicity in developing countries. We hypothesised that neonatal vitamin A supplementation (NVAS) would improve oral vaccine responses.</AbstractText><AbstractText Label="METHODS">We performed a cross-sectional study of infants recruited at birth to the Zimbabwe Vitamin A for Mothers and Babies (ZVITAMBO) trial, a randomised controlled trial of single, high-dose NVAS vs placebo conducted in Zimbabwe between 1997-2001. We measured poliovirus-specific IgA to type 1-3 polio strains by semiquantitative capture ELISA in cryopreserved plasma samples collected at 6 months of age.</AbstractText><AbstractText Label="RESULTS">A total of 181 infants fulfilled inclusion criteria, of whom 80 were randomised to NVAS and 101 to placebo. There were no significant differences in baseline characteristics between groups. At 6 months of age, median (IQR) vaccine titres for infants randomised to NVAS vs placebo were 932 (421-3001) vs 1774 (711-5431) for Sabin-1 (p=0.04); 1361 (705-3402) vs 2309 (1081-4283) for Sabin-2 (p=0.15); and 1584 (796-4216) vs 2260 (996-5723) for Sabin-3 (p=0.14), respectively. After adjusting for breast feeding status, birth weight, season and infant sex in a linear regression model, there was only weak evidence of difference in log mean titres between vitamin A and placebo groups for Sabin-1 (p=0.08) and no evidence of difference in log mean titres for Sabin-2 and Sabin-3.</AbstractText><AbstractText Label="CONCLUSIONS">NVAS did not augment oral polio vaccine responses in Zimbabwean infants. Further research is required to understand the impact of NVAS on responses to other oral vaccines.The trial is registered with clinicaltrials.gov identifier: NCT00198718.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2018. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Church</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Genomics &amp; Child Health, Blizard Institute, Queen Mary University of London, Newark Street, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rukobo</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Govha</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmolli</LastName><ForeName>Marya P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center, Larner College of Medicine, University of Vemont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diehl</LastName><ForeName>Sean A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center, Larner College of Medicine, University of Vemont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasekwa</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntozini</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mutasa</LastName><ForeName>Kuda</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Jean H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Beth D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Vaccine Testing Center, Larner College of Medicine, University of Vemont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prendergast</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, 16 Lauchlan Avenue, Harare, Zimbabwe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Genomics &amp; Child Health, Blizard Institute, Queen Mary University of London, Newark Street, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00198718</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P20 GM125498</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 RR021905</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM118228</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trans R Soc Trop Med Hyg</MedlineTA><NlmUniqueID>7506129</NlmUniqueID><ISSNLinking>0035-9203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>11103-57-4</RegistryNumber><NameOfSubstance UI="D014801">Vitamin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014801" MajorTopicYN="N">Vitamin A</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015030" MajorTopicYN="N" Type="Geographic">Zimbabwe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">OPV</Keyword><Keyword MajorTopicYN="N">infants</Keyword><Keyword MajorTopicYN="N">oral vaccine</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">vitamin A</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30576507</ArticleId><ArticleId IdType="pmc">PMC6391935</ArticleId><ArticleId IdType="doi">10.1093/trstmh/try126</ArticleId><ArticleId IdType="pii">5253778</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Czerkinsky C, Holmgren J. Vaccines against enteric infections for the developing world. Philos Trans R Soc Lond B Biol Sci. 2015;370(1671):20150142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4527397</ArticleId><ArticleId IdType="pubmed">25964464</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci. 2013;368(1623):20120140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720038</ArticleId><ArticleId IdType="pubmed">23798688</ArticleId></ArticleIdList></Reference><Reference><Citation>Armah GE, Sow SO, Breiman RF, et al. . Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">20692030</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque R, Snider C, Liu Y, et al. . Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2014;32(4):478&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4936916</ArticleId><ArticleId IdType="pubmed">24300591</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado YA, Pena-Cruz V, de la Luz Sanchez M, et al. . Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. J Infect Dis 1997;175(3):545&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110245</ArticleId><ArticleId IdType="pubmed">9041324</ArticleId></ArticleIdList></Reference><Reference><Citation>Posey DL, Linkins RW, Oliveria MJ, et al. . The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis. 1997;175(Suppl 1):S258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">9203726</ArticleId></ArticleIdList></Reference><Reference><Citation>Triki H, Abdallah MV, Ben Aissa R, et al. . Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine. 1997;15(10):1123&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9269056</ArticleId></ArticleIdList></Reference><Reference><Citation>Church JA, Parker EP, Kosek MN, et al. . Exploring the relationship between environmental enteric dysfunction and oral vaccine responses. Future Microbiol. 2018; Epub 21 June.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6136084</ArticleId><ArticleId IdType="pubmed">29926747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiseman EM, Bar-El Dadon S, Reifen R. The vicious cycle of vitamin A deficiency: A review. Crit Rev Food Sci Nutr. 2016:57(17):3703&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">27128154</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Vitamin A supplementation for infants and children 6&#x2013;59 months of age: Guideline. 2011. Report No.: 978 92 4 150176 7.</Citation></Reference><Reference><Citation>Haider BA, Bhutta ZA. Neonatal vitamin A supplementation: time to move on. Lancet. 2015;385(9975):1268&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">25499547</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmond KM, Newton S, Shannon C, et al. . Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;385(9975):1315&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25499545</ArticleId></ArticleIdList></Reference><Reference><Citation>Masanja H, Smith ER, Muhihi A, et al. . Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;385(9975):1324&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419827</ArticleId><ArticleId IdType="pubmed">25499543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazumder S, Taneja S, Bhatia K, et al. . Efficacy of early neonatal supplementation with vitamin A to reduce mortality in infancy in Haryana, India (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;385(9975):1333&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">25499546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman DR, De Calisto J, Simmons NL, et al. . Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity. J Immunol. 2011;187(4):1877&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150351</ArticleId><ArticleId IdType="pubmed">21765014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisulo MM, Kapulu MC, Banda R, et al. . Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men. Clin Exp Immunol. 2014;175(3):468&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3927907</ArticleId><ArticleId IdType="pubmed">24237035</ArticleId></ArticleIdList></Reference><Reference><Citation>Benn CS. Combining vitamin A and vaccines: convenience or conflict? Dan Med J. 2012;59(1):B4378.</Citation><ArticleIdList><ArticleId IdType="pubmed">22239846</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinda E, Humphrey JH, Iliff PJ, et al. . Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007;26(6):519&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">17529870</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey JH, Hargrove JW, Malaba LC, et al. . HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS. 2006;20(10):1437&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">16791019</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey JH, Iliff PJ, Marinda ET, et al. . Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006;193(6):860&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">16479521</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaba LC, Iliff PJ, Nathoo KJ, et al. . Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. Am J Clin Nutr. 2005;81(2):454&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson RS. Principles of Nutritional Assessment. 2nd ed New York, USA: 2005: Oxford University Press; 1990:712.</Citation></Reference><Reference><Citation>Iliff PJ, Piwoz EG, Tavengwa NV, et al. . Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19(7):699&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">15821396</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Immunization coverage: reported coverage by country, year and vaccine. 2016.</Citation></Reference><Reference><Citation>Ivanov AP, Dragunsky EM. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev Vaccines. 2005;4(2):167&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15889990</ArticleId></ArticleIdList></Reference><Reference><Citation>Simhon A, Lifshitz A, Abed Y, et al. . How to Predict the Immune Status of Poliovirus Vaccinees&#x2014;a Comparison of Virus Neutralization at a Very Low Serum Dilution Versus Elisa in a Cohort of Infants. Int J Epidemiol 1990;19(1):164&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2161806</ArticleId></ArticleIdList></Reference><Reference><Citation>Gary BE, Freeman C, Penaranda S, et al. . Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine. J Infect Dis. 1997;175:S264&#x2013;S7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9203727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashido M, Horie H, Abe S, et al. . Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies. Microbiol Immunol. 1999;43(1):73&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10100750</ArticleId></ArticleIdList></Reference><Reference><Citation>Herremans T, Kimman TG, Conyn-van Spaendonck MAE, et al. . Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis. 2002;34(8):1067&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright PF, Wieland-Alter W, Ilyushina NA, et al. . Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination. J Infect Dis. 2014;209(10):1628&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">24459191</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DJ, Gahnberg L, Taubman MA, et al. . Salivary antibody responses to oral and parenteral vaccines in children. J Clin Immunol. 1986;6(1):43&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3958136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3330118</ArticleId><ArticleId IdType="pubmed">22532797</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldon WC, Oberste MS, Pallansch MA. Standardized Methods for Detection of Poliovirus Antibodies. Methods Mol Biol. 2016;1387:145&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">26983734</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaby P, Vessari H, Nielsen J, et al. . Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J. 2006;25(8):721&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16874172</ArticleId></ArticleIdList></Reference><Reference><Citation>John TJ, Devarajan LV, Luther L, et al. . Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination. Pediatrics. 1976;57(1):47&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">174056</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman MM, Alvarez JO, Mahalanabis D, et al. . Effect of vitamin A administration on response to Oral Polio Vaccination. Nutr Res. 1998;18(7):1125&#x2013;33.</Citation></Reference><Reference><Citation>Semba RD, Muhilal, Mohgaddam NE, et al. . Integration of vitamin A supplementation with the expanded program on immunization does not affect seroconversion to oral poliovirus vaccine in infants. J Nutr. 1999;129(12):2203&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10573550</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton S, Cousens S, Owusu-Agyei S, et al. . Vitamin a supplementation does not affect infants&#x2019; immune responses to polio and tetanus vaccines. J Nutr. 2005;135(11):2669&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">16251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl R, Bhandari N, Kant S, et al. . Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine. Eur J Clin Nutr 2002;56(4):321&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11965508</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmathullah L, Tielsch JM, Thulasiraj RD, et al. . Impact of supplementing newborn infants with vitamin A on early infant mortality: community based randomised trial in southern India. BMJ. 2003;327(7409):254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC167159</ArticleId><ArticleId IdType="pubmed">12896935</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider BA, Sharma R, Bhutta ZA. Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries. Cochrane Database Syst Rev. 2017;2:CD006980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464547</ArticleId><ArticleId IdType="pubmed">28234402</ArticleId></ArticleIdList></Reference><Reference><Citation>Force WUIT Vitamin A supplements: a guide to their use in the treatment and prevention of vitamin A deficiency and xerophthalmia. Geneva: WHO; 1998.</Citation></Reference><Reference><Citation>Smith ER, Muhihi A, Mshamu S, et al. . The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial. Int J Epidemiol. 2016:45(6):2112&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841838</ArticleId><ArticleId IdType="pubmed">27789674</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>